Citation: S. Norgren et al., EXPERIMENTAL INVESTIGATION ON THE ENTHALPIES OF FORMATION OF THE DYFE2, DYFE3, DY2FE17, ERFE2, AND ERFE3 INTERMETALLIC COMPOUNDS, Metallurgical and materials transactions. A, Physical metallurgy andmaterials science, 29(5), 1998, pp. 1367-1374
Authors:
KAMEL A
NORGREN S
LINDGREN AC
LUTHMAN H
ARNER P
MARCUS C
Citation: A. Kamel et al., EFFECT OF GROWTH-HORMONE TREATMENT ON INSULIN ACTION IN ADIPOCYTES FROM CHILDREN WITH PRADER-WILLI-SYNDROME, European journal of endocrinology, 138(5), 1998, pp. 510-516
Citation: S. Norgren et J. Agren, ENTHALPIES OF FORMATION OF TRANSITION-METAL LANTHANIDE LAVES PHASES WITH THE MGCU2 STRUCTURE, Journal of phase equilibria, 18(5), 1997, pp. 441-447
Authors:
KAMEL A
NORGREN S
EHREN H
HILDINGSSON U
MARCUS C
Citation: A. Kamel et al., ANTILIPOLYTIC EFFECT OF INSULIN AND INSULIN-RECEPTOR MESSENGER-RNA EXPRESSION IN ADIPOCYTES OF INFANTS, CHILDREN, AND ADULTS, Pediatric research, 41(4), 1997, pp. 563-567
Authors:
INOUE K
NORGREN S
LUTHMAN H
MOLLER C
GRILL V
Citation: K. Inoue et al., B-CELLS OF AGING RATS - IMPAIRED STIMULUS-SECRETION COUPLING BUT NORMAL SUSCEPTIBILITY TO ADVERSE-EFFECTS OF A DIABETIC STATE, Metabolism, clinical and experimental, 46(3), 1997, pp. 242-246
Authors:
JOHNSTON JA
NORGREN S
ANNEREN G
COWBURN RF
LANNFELT L
Citation: Ja. Johnston et al., A NEW QUANTITATIVE SOLUTION HYBRIDIZATION-RNASE PROTECTION ASSAY FOR APP AND APLP2 MESSENGER-RNA, Molecular brain research, 43(1-2), 1996, pp. 77-84
Authors:
JOHNSTON JA
NORGREN S
RAVID R
WASCO W
WINBLAD B
LANNFELT L
COWBURN RF
Citation: Ja. Johnston et al., QUANTIFICATION OF APP AND APLP2 MESSENGER-RNA IN APOE GENOTYPED ALZHEIMERS-DISEASE BRAINS, Molecular brain research, 43(1-2), 1996, pp. 85-95
Authors:
JOHNSTON J
COWBURN R
WIEHAGER B
NORGREN S
LANNFELT L
VIGOPELFREY C
SCHENK D
CITRON M
SELKOE D
ONEILL C
Citation: J. Johnston et al., AMYLOID PRECURSOR PROTEIN EXPRESSION AND BETA-AMYLOID RELEASE IN FIBROBLAST CELL-LINES OBTAINED FROM FAMILY MEMBERS WITH THE SWEDISH APP670671 MUTATION/, Neurobiology of aging, 15, 1994, pp. 190000071-190000071
Authors:
NORGREN S
ZIERATH J
WEDELL A
WALLBERGHENRIKSSON H
LUTHMAN H
Citation: S. Norgren et al., REGULATION OF HUMAN INSULIN-RECEPTOR RNA SPLICING IN-VIVO, Proceedings of the National Academy of Sciences of the United Statesof America, 91(4), 1994, pp. 1465-1469
Citation: S. Norgren et al., INSULIN-RECEPTOR RIBONUCLEIC-ACID LEVELS AND ALTERNATIVE SPLICING IN HUMAN LIVER, MUSCLE, AND ADIPOSE-TISSUE - TISSUE-SPECIFICITY AND RELATION TO INSULIN ACTION, The Journal of clinical endocrinology and metabolism, 78(3), 1994, pp. 757-762
Authors:
JOHNSTON JA
COWBURN RF
NORGREN S
WIEHAGER B
VENIZELOS N
WINBLAD B
VIGOPELFREY C
SCHENK D
LANNFELT L
ONEILL C
Citation: Ja. Johnston et al., INCREASED BETA-AMYLOID RELEASE AND LEVELS OF AMYLOID PRECURSOR PROTEIN (APP) IN FIBROBLAST CELL-LINES FROM FAMILY MEMBERS WITH THE SWEDISH ALZHEIMERS-DISEASE APP670 671 MUTATION/, FEBS letters, 354(3), 1994, pp. 274-278
Authors:
VITOLS S
NORGREN S
JULIUSSON G
TATIDIS L
LUTHMAN H
Citation: S. Vitols et al., MULTILEVEL REGULATION OF LOW-DENSITY-LIPOPROTEIN RECEPTOR AND 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE GENE-EXPRESSION IN NORMAL ANDLEUKEMIC-CELLS, Blood, 84(8), 1994, pp. 2689-2698
Citation: S. Norgren et al., REGULATION OF HUMAN INSULIN-RECEPTOR RNA SPLICING IN HEPG2 CELLS - EFFECTS OF GLUCOCORTICOID AND LOW GLUCOSE-CONCENTRATION, Biochemical and biophysical research communications, 199(1), 1994, pp. 277-284
Authors:
NORGREN S
ZIERATH J
GALUSKA D
WALLBERGHENRIKSSON H
LUTHMAN H
Citation: S. Norgren et al., DIFFERENCES IN THE RATIO OF RNA ENCODING 2 ISOFORMS OF THE INSULIN-RECEPTOR BETWEEN CONTROL AND NIDDM PATIENTS - THE RNA VARIANT WITHOUT EXON-11 PREDOMINATES IN BOTH GROUPS, Diabetes, 42(5), 1993, pp. 675-681